Ribavirin Discontinuations for Adverse Events / Lab Abnormalities
24 weeks
48 weeks
Discontinuations (%)
7%
6%
18%
19%
PEGASYSĘ RBV 800
PEGASYSĘ RBV 1000/1200
PEGASYSĘ RBV 800
PEGASYSĘ RBV 1000/1200
Previous slide
Next slide
Back to first slide
View graphic version
Notes:
Increase in ribavirin discontinuation when treatment duration extended.